glp 1 mental side effects GLP-1 Agonist for Binge Eating Disorder: Evidence and Safety If you've ever found yourself

When speaking with People, Oprah Winfrey echoed similar sentiments

Despite these favorable mechanisms, concerns remain regarding the impact of GLP-1 RAs on lean body mass (LBM) and the potential risk of sarcopenia

Herein, we briefly describe therapeutic agents/compounds that enhance GLP-1 function

Companies like Noom and Hims have also launched programs to prescribe microdosed GLP-1s, claiming that these smaller doses can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline. Evidence of sustained patient use post-shortage: Prescription volume and utilization of compounded semaglutide and tirzepatide have continued to grow despite the end of medication shortages, suggesting that compounders may be leveraging additives or dosage adjustments to justify production

PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols